Partner Section
Recent Developments-2010
Chrono Therapeutics Inc. receives notification from the European Patent Office that an additional key patent for CHRONODOSE™ has been granted. This new patent grant affirms the novelty of CTI’s technology and believes it will considerably reduce any potential risk to the CTI group.
Chrono Therapeutics Inc. is featured in Transdermal Magazine.
(SEE PAGE 6)
Product Pipeline
CTI-A Drug Product Company
CTI is a drug product company with a robust drug product pipeline.
We are taking to market revolutionary, life-enhancing and in certain cases, life-saving drug products. We are in human clinical trials for our lead drug product, and we are performing extensive pre-clinical development on four of our follow-on drug products.
Our family of ChronoDose™ products improves therapy for the elderly, children, institutional patients and everyday people.